Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

56.18 -1.81 (-3.12%)
Streaming Delayed Price Updated: 3:31 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
34 35 Next >
News headline image
This 1 Innovation Could Make These 2 Biotechs Soar by 2030 ↗
Simplifying the cell therapy manufacturing process could be worth a lot of money. 
Via The Motley Fool
News headline image
2 Soaring Stocks With More Upside Potential ↗
Are these mid-cap stocks giants in the making? 
Via The Motley Fool
News headline image
Is Now a Good Time to Buy CRISPR Therapeutics? ↗
CRISPR shares have climbed more than 40% this year. 
Via The Motley Fool
News headline image
3 Tech Stocks to Watch for Groundbreaking Innovations in 2030 ↗
If you’re a speculative investor here are three companies that are on the leading edge of what may be groundbreaking innovations by 2030. 
Via InvestorPlace
News headline image
2 Monster Stocks to Buy Without Any Hesitation ↗
These players each bring in billions of dollars in earnings every year. 
Via The Motley Fool
News headline image
Cathie Wood Is Buying These 3 Growth Stocks Hand Over Fist. Should You? ↗
The captain of innovation-focused investing can't seem to get enough of these beaten-down growth stocks. 
Via The Motley Fool
News headline image
2 Magnificient Growth Stocks to Buy in July ↗
These two growth stocks might be incredibly undervalued right now. 
Via The Motley Fool
News headline image
Vertex Pharmaceuticals Stock: Bear vs. Bull ↗
Vertex has reached a key moment in its story. 
Via The Motley Fool
News headline image
2 Under-the-Radar Biotech Stocks to Buy in 2023 ↗
These companies are coming into their own. 
Via The Motley Fool
News headline image
3 Pharma Stocks That AI is Loving in July ↗
Artificial intelligence recommends that these are the three stocks to consider when investing in pharma stocks. 
Via InvestorPlace
News headline image
2 No-Brainer Healthcare Stocks to Buy With $100 Right Now ↗
These stocks may not stay this low for long. 
Via The Motley Fool
News headline image
3 Top Biotech Stocks Defying the Bear Market ↗
Each has the potential to dramatically outperform the market. 
Via The Motley Fool
News headline image
3 Biotech Stocks to Buy for Long-Term Gains
The biotech sector is one of the most volatile sectors, but here are three biotech stocks that offer opportunities for patient biotech stock investors. 
Via MarketBeat
Topics ETFs Economy
News headline image
3 Things About Vertex Pharmaceuticals That Smart Investors Know ↗
Vertex shares have advanced about 20% so far this year. 
Via The Motley Fool
News headline image
2 Top Healthcare Stocks Defying the Bear Market ↗
These stocks are rising in the double digits -- and outperforming the S&P 500. 
Via The Motley Fool
News headline image
Sitting on Cash? These 2 Stocks Are Great Buys ↗
Coca-Cola and Vertex Pharmaceuticals are excellent choices to add to your portfolio for the long term. 
Via The Motley Fool
News headline image
3 Growth Stocks With 55% to 71% Upside, According to Wall Street ↗
Find out why investment bank analysts are so bullish on these stocks. 
Via The Motley Fool
News headline image
2 Growth Stocks That Might Be Too Cheap to Ignore ↗
The sky is the limit for these healthcare companies. 
Via The Motley Fool
News headline image
Thoughts For Thursday: Back From The Holiday With Caution ↗
Caution is perhaps what was reflected in yesterday's back from the holiday trading. One there is the question of upcoming Fed action and second there is the visit of Secretary Yellen to China. 
Via Talk Markets
News headline image
3 Biotech Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2025 ↗
In researching this article, we used AI to help make predictions for potential triple-digit return biotech stocks by 2025 
Via InvestorPlace
News headline image
Cathie Wood Continues To Sell Tesla Shares Amid Q2 Deliveries-Induced Strength: Here's How Much Shares Ark Offloaded Monday ↗
 
Via Benzinga
News headline image
3 Stocks That Every 20-Year-Old Should Buy Today ↗
When you’re just starting out in adult life, you have time on your side. Use it to your advantage with these stocks for young investors. 
Via InvestorPlace
News headline image
The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023 ↗
If you dig deep enough, you’ll find some undervalued biotech stocks with substantial catalysts straight ahead. 
Via InvestorPlace
News headline image
This 1 Problem Could Sink at Least 4 Gene-Editing Stocks ↗
Reaching profitability could be harder than investors expect. 
Via The Motley Fool
News headline image
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond ↗
Both companies have therapies that should help grow revenue and earnings for years. 
Via The Motley Fool
News headline image
The Best Stocks to Invest $20,000 in Right Now ↗
You can invest in these companies with $20,000 -- or even a lot less. 
Via The Motley Fool
News headline image
Why Shares of Nkarta Are Slumping Tuesday ↗
The pharmaceutical stock dropped after announcing so-so clinical trial results. 
Via The Motley Fool
News headline image
Wall Street Estimates That CRISPR Therapeutics Stock Could Jump 49%. Here's Why That's Right. ↗
With two huge catalysts drawing near, its stock could go even higher. 
Via The Motley Fool
News headline image
What Is CRISPR And Why Should Your Portfolio Care? ↗
CRISPR Therapeutics continues to be at the forefront of CRISPR-based therapeutics development. It's the first, and largest, but not the only player. 
Via Talk Markets
News headline image
3 Monster Stocks in the Making to Buy Right Now ↗
They're not monsters now -- but just give them some time. 
Via The Motley Fool
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.